Veterinary Medicines Information website

Albiotic intramammær opløsning 10+33 mg/ml

Authorised
  • Neomycin
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Albiotic intramammær opløsning 10+33 mg/ml
Active substance:
  • Neomycin
  • Lincomycin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Neomycin
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Lincomycin
    330.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RG01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Manufacturing Belgium
  • Biovet AD
  • Zoetis Belgium SA
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 19240
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
Download